Ibu-Lysin Al (Ibuprofen)

Ibuprofen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for the conversion of arachidonic acid into prostaglandins. By lowering prostaglandin levels, ibuprofen reduces inflammation, alleviates pain, and helps lower body temperature.

The appropriate dose of Ibu-Lysin Al is determined by the prescribing healthcare professional based on the patient’s age, weight, medical condition, and response to therapy. Dosage regimens are individualized and should follow the prescriber’s instructions without deviation.

Safety of ibuprofen during pregnancy and lactation depends on the trimester and clinical circumstances. Generally, ibuprofen is avoided in the third trimester because of potential fetal risks, and it should only be used during pregnancy or while breastfeeding if the prescriber judges that the benefits outweigh the risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Ibu-Lysin Al. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Both ibuprofen and naproxen belong to the NSAID class and share similar mechanisms of COX inhibition. Ibuprofen generally has a shorter half‑life, requiring more frequent dosing, while naproxen offers a longer duration of action. Choice between them depends on clinical factors, patient tolerance, and prescriber preference.

Ibu-Lysin Al should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging to protect them from moisture, light, and excessive heat. Do not store in a refrigerator or freezer unless otherwise directed by the supplier.

Ibu-Lysin Al is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. The tablet should be swallowed whole and not chewed or crushed unless specifically instructed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, severe renal impairment, anaphylactic reactions, and rare but severe skin reactions such as Stevens‑Johnson syndrome. Patients with a history of ulcers, kidney disease, or cardiovascular disease should be monitored closely, and any signs of serious adverse events require immediate medical attention.

Ibu-Lysin Al should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulcer disease, severe renal or hepatic impairment, and in the third trimester of pregnancy. Patients on anticoagulant therapy or with uncontrolled hypertension should also discuss use with their prescriber before starting treatment.